Part D/Prescription Drugs – Page 21 – medicarereport.org

Tuesday, December 9, 2025

Latest:

Employer Healthcare Health Care Finance Health Insurance Part D/Prescription Drugs

Eileen Cook August 23, 2024August 23, 2024 Cancer Care, Employer Health Insurance, Healthcare Costs, Healthcare Finance, Musculoskeletal, Pharmacy

The 3 conditions driving healthcare costs up for employers: Report

(By Mariah Taylor for Becker’s Hospital Review) Pharmacy, cancer and musculoskeletal conditions remain the top drivers of increased healthcare costs

CMS FDA Health Care Finance Health Care Redesign HHS Part D/Prescription Drugs

Eileen Cook August 21, 2024August 21, 2024 CMS, Healthcare Costs, Healthcare Finance, Inflation Reduction Act of 2022, medicare, Medicare Drug Price Negotiation Program, Medicare Part D, Older Adults

FAQs about the Inflation Reduction Act’s Medicare Drug Price Negotiation Program

(By Juliette Cubanski for The Kaiser Family Foundation Published: Aug 20, 2024) The Inflation Reduction Act of 2022 (the Act),

FDA Part D/Prescription Drugs

Eileen Cook August 19, 2024August 19, 2024 Drug Shortages, FDA, Medicare Part D

5 drugs now in shortage

(By Paige Twenter for Becker’s Hospital Review) About two-thirds of providers recently told Premier their teams are spending more than

CMS Health Care Finance Part D/Prescription Drugs

Eileen Cook August 16, 2024August 16, 2024 CMS, Drugs for Weight Loss, GLP-1 drugs, Healthcare Finance, medicare, Medicare Part D, Older Adults

Weight loss drugs could cost Medicare $6B a year: Study

(By Rylee Wilson for Becker’s Hospital Review) Medicare spending could increase between $3.1 billion and $6.1 billion annually if the

Employer Healthcare Health Care Finance Health Insurance HHS Part D/Prescription Drugs

Eileen Cook August 15, 2024August 15, 2024 Employer Health Insurance, Health Insuarnce, Healthcare Costs, Healthcare Finance, Medicare Drug Price Negotiation Program, Medicare Part D, Private Health Plans

While Medicare Drug Price Negotiations Don’t Apply to Private Insurance, 3.4 Million People with Employer Coverage Take at Least One of the Selected Drugs

(Tammie Smith for The Kaiser Family Foundation published August 14, 2024) Among the 167 million people with employer-sponsored insurance in

CMS Health Care Finance Health Care Redesign HHS Part D/Prescription Drugs

Eileen Cook August 15, 2024August 15, 2024 CMS, Healthcare Finance, HHS, Medicare Negotiations, Medicare Part D

Medicare negotiated drug prices for the first time. Here’s what it got

(By Sydney Lupkin, Asma Khalid for NPR) The White House unveiled the fruits of months of negotiations between the government

Employer Healthcare Health Care - General Health Insurance Medicaid Medicare - General Part D/Prescription Drugs

Eileen Cook August 14, 2024August 14, 2024 Commercial Health Insurance, Employer Health Insurance, Healthcare Costs, Healthcare Finance, Medicaid, medicare, Ozempic, Semaglutide

Majority of weight loss drug prescriptions going to commercially insured patients

(By Jakob Emerson for Becker’s Hospital Review) In 2023, more than 61% of Ozempic prescriptions went to patients with commercial

FDA Part D/Prescription Drugs

Eileen Cook August 12, 2024August 12, 2024 Cancer Drugs, FDA, Krazati, Misleading claims

FDA calls out Bristol Myers over cancer drug claims

(By Elizabeth Gregerson for Becker’s Hospital Review) The FDA has accused pharmaceutical company Bristol Myers Squibb of making false or

FDA Part D/Prescription Drugs PTSD

Eileen Cook August 12, 2024August 12, 2024 FDA, MDMA, PTSD

FDA gives thumbs down to MDMA for now, demanding further research

(By Will Stone for NPR) On Friday, drugmaker Lykos Therapeutics received word from the Food and Drug Administration that the

CMS Health Care Finance Medicare - General Medicare Advantage Part D/Prescription Drugs

Eileen Cook August 9, 2024August 9, 2024 CMS, Healthcare Costs, Healthcare Finance, medicare, Medicare Advantage, Medicare Advantage Prior Authorization, Medicare Part D, MedPAC, Older Adults, Supplemental Benefits

Medicare Advantage in 2024: Premiums, Out-of-Pocket Limits, Supplemental Benefits, and Prior Authorization

(By Meredith Freed, Jeannie Fuglesten Biniek, Anthony Damico, and Tricia Neuman for The Kaiser Family Foundation Published: Aug 08, 2024)